Myriad Genetics | MYGN - Cost Of Sales

Stock Price
3.81
Daily Change
0.26 7.32%
Monthly
-23.65%
Yearly
-6.39%
Q2 Forecast
3.51

Myriad Genetics reported $63M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Bio-Rad Laboratories USD 348M 38.4M Dec/2025
Bruker USD 443.6M 84.4M Mar/2026
Danaher USD 2.36B 512M Mar/2026
Illumina USD 370M 30M Mar/2026
J&J USD 8.07B 103M Mar/2026
Mettler Toledo International USD 410.92M 63.05M Mar/2026
Myriad Genetics USD 63M 1.1M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Quest Diagnostics USD 1.99B 57M Mar/2026
Quidel USD -79.5M 528.3M Mar/2026
Repligen USD 85.97M 8.11M Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Standard Biotools USD 12.41M 2.34M Dec/2025
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Veracyte USD 38.49M 794K Mar/2026
Waters USD 725M 350.06M Mar/2026